Solebo Ameenat Lola, Russell-Eggitt Isabelle, Cumberland Phillippa M, Rahi Jugnoo S
Life Course Epidemiology and Biostatistics Section, University College London Institute of Child Health, London, UK NIHR Moorfields Biomedical Research Centre / Institute of Ophthalmology, University College London, London, UK Ulverscroft Vision Research Group, Institute of Child Health, University College London, London, UK.
Ulverscroft Vision Research Group, Institute of Child Health, University College London, London, UK Great Ormond Street Hospital for Children, London, UK.
Br J Ophthalmol. 2015 Nov;99(11):1471-6. doi: 10.1136/bjophthalmol-2014-306394. Epub 2015 May 6.
BACKGROUND/AIMS: To investigate outcomes following cataract surgery with and without primary intraocular lens (IoL) implantation in children under 2 years of age with congenital or infantile cataract.
Prospective population based cohort study undertaken through the British Isles Congenital Cataract Interest Group, with systematic data collection on children undergoing surgery in UK and Ireland between January 2009 and December 2010. ORs for the association between IoL implantation and visual acuity, postoperative glaucoma and reoperation at 1 year after surgery were estimated using multivariable regression analysis to control for potential confounders.
Of 221 children, 56/131 with bilateral and 48/90 with unilateral cataract underwent primary IoL implantation. IoL implantation was independently associated with better visual outcome in bilateral (OR 4.6, 95% CI 1.6 to 13.1, p=0.004) but not unilateral disease. IoL use increased the odds of reoperation requiring repeat general anaesthetic (bilateral OR 5.5, p<0.01; unilateral OR 16.7, p<0.01). IoL implantation did not reduce the odds of postoperative glaucoma.
The use of IoLs in cataract surgery in young children should be critically reassessed, particularly used in settings/communities where close, long-term follow-up is challenging. The absence of visual benefit and the lack of a previously postulated protective effect against postoperative glaucoma serve to question the value of IoLs in unilateral disease. The potential association between IoL use and better early visual outcomes in bilateral disease needs to be balanced against the risk of reoperation and exposure to additional general anaesthetics during a key period of neurodevelopment.
背景/目的:研究2岁以下患有先天性或婴儿性白内障的儿童在白内障手术中植入与未植入人工晶状体(IOL)后的预后情况。
通过不列颠群岛先天性白内障兴趣小组开展前瞻性基于人群的队列研究,对2009年1月至2010年12月期间在英国和爱尔兰接受手术的儿童进行系统的数据收集。使用多变量回归分析估计IOL植入与术后1年视力、术后青光眼和再次手术之间的关联的比值比(OR),以控制潜在的混杂因素。
在221名儿童中,56例双侧白内障和48例单侧白内障患儿接受了一期IOL植入。IOL植入与双侧白内障(OR 4.6,95%CI 1.6至13.1,p = 0.004)而非单侧白内障的更好视觉预后独立相关。IOL的使用增加了需要再次全身麻醉进行再次手术的几率(双侧OR 5.5,p < 0.01;单侧OR 16.7,p < 0.01)。IOL植入并未降低术后青光眼的几率。
应严格重新评估在幼儿白内障手术中使用IOL的情况,尤其是在密切、长期随访具有挑战性的环境/社区中。缺乏视觉益处以及对术后青光眼缺乏先前假定的保护作用,质疑了IOL在单侧疾病中的价值。在双侧疾病中,IOL使用与更好的早期视觉预后之间的潜在关联需要与再次手术的风险以及在神经发育关键期暴露于额外全身麻醉的风险相权衡。